10-K
10-K Filing
- Company
- INTEGRATED BIOPHARMA INC
- Filed
- October 13, 2011
- Period of Report
- June 30, 2011
- Accession Number
- 0001016504-11-000011
A 10-K is a company's comprehensive annual report, required by the SEC. It includes audited financial statements, a description of the business, risk factors, and management's discussion of results. Learn more about 10-K filings →